Short Courses
Short Courses
GC
22 September 2009
Explore GC in the Fast Lane
Philadelphia, PA.
Contact: Website: www.lcgcevent.com/lcgcevent/v42/index.cvn?id=10003
9–13 November 2009
Gas Chromatography: Fundamentals, Troubleshooting, and Method Development
Chicago, IL.
Contact: Website: www.acs.org
HPLC
17 August 2009
Practical HPLC in Pharmaceutical Analysis
Washington, D.C.
Contact: Website: www.acs.org
19–20 August 2009
Fundamentals of High Performance Liquid Chromatography
Washington, D.C.
Contact: Website: www.acs.org
14–15 September 2009
Normal & Reversed Phase HPLC
Tarrytown, NY.
Contact: Ronald Sutton, Chromatography Institute; tel: 1-800-788-9922,
Website: www.HPLCinstitute.com
16 September 2009
HPLC Maintenance & Troubleshooting
Tarrytown, NY.
Contact: Ronald Sutton, Chromatography Institute; tel: 1-800-788-9922,
Website: www.HPLCinstitute.com
16 and 18 September 2009
HPLC Certification Examination
Tarrytown, NY.
Contact: Ronald Sutton, Chromatography Institute; tel: 1-800-788-9922,
Website: www.HPLCinstitute.com
17–18 September 2009
HPLC Analysis and Purifications of Proteins & Peptides
Tarrytown, NY.
Contact: Ronald Sutton, Chromatography Institute; tel: 1-800-788-9922,
Website: www.HPLCinstitute.com
21 September 2009
Develop a Painless Migration Roadmap to UHPLC
Philadelphia, PA.
Contact: Website: www.lcgcevent.com/lcgcevent/v42/index.cvn?id=10003
21 September 2009
Applications in UHPLC Instrumentation and Column Technology
Philadelphia, PA.
Contact: Website: www.lcgcevent.com/lcgcevent/v42/index.cvn?id=10003
22 September 2009
Know the Advantages of Using HPLC — Charged Aerosol Detection (CAD) in Pharmaceutical Analysis
Philadelphia, PA.
Contact: Website: www.lcgcevent.com/lcgcevent/v42/index.cvn?id=10003
22 September 2009
Accomplish Accurate Concentration, Mole Percent and Residue Composition Data — Amino Acid Analysis by UHPLC
Philadelphia, PA.
Contact: Website: www.lcgcevent.com/lcgcevent/v42/index.cvn?id=10003
12–13 October 2009
Normal & Reversed Phase HPLC
Boston, MA.
Contact: Ronald Sutton, Chromatography Institute; tel: 1-800-788-9922,
Website: www.HPLCinstitute.com
14 October 2009
HPLC Maintenance & Troubleshooting
Boston, MA.
Contact: Ronald Sutton, Chromatography Institute; tel: 1-800-788-9922,
Website: www.HPLCinstitute.com
14 and 16 October 2009
HPLC Certification Examination
Boston, MA.
Contact: Ronald Sutton, Chromatography Institute; tel: 1-800-788-9922,
Website: www.HPLCinstitute.com
15–16 October 2009
HPLC Analysis and Purifications of Proteins & Peptides
Boston, MA.
Contact: Ronald Sutton, Chromatography Institute; tel: 1-800-788-9922,
Website: www.HPLCinstitute.com
9–10 November 2009
Normal & Reversed Phase HPLC
San Diego, CA.
Contact: Ronald Sutton, Chromatography Institute; tel: 1-800-788-9922,
Website: www.HPLCinstitute.com
11 November 2009
HPLC Maintenance & Troubleshooting
San Diego, CA.
Contact: Ronald Sutton, Chromatography Institute; tel: 1-800-788-9922,
Website: www.HPLCinstitute.com
11 and 13 November 2009
HPLC Certification Examination
San Diego, CA.
Contact: Ronald Sutton, Chromatography Institute; tel: 1-800-788-9922,
Website: www.HPLCinstitute.com
12–13 November 2009
HPLC Analysis and Purifications of Proteins & Peptides
San Diego, CA.
Contact: Ronald Sutton, Chromatography Institute; tel: 1-800-788-9922,
Website: www.HPLCinstitute.com
LC–MS
17 August 2009
High-Throughput Drug Analysis by LC–MS
Washington, D.C.
Contact: Website: www.acs.org
21 September 2009
Fast LC and MS Techniques with Biogenerics
Philadelphia, PA.
Contact: Website: www.lcgcevent.com/lcgcevent/v42/index.cvn?id=10003
21 September 2009
Improve Speed, Efficiency and Green Chemistry through High Temperature LC
Philadelphia, PA.
Contact: Website: www.lcgcevent.com/lcgcevent/v42/index.cvn?id=10003
21 September 2009
Expand the Scope of Application with LC–MS and LC–MS-MS
Philadelphia, PA.
Contact: Website: www.lcgcevent.com/lcgcevent/v42/index.cvn?id=10003
21 September 2009
A Quality-by-Design (QbD) Approach to Rapid LC Method Development
Philadelphia, PA.
Contact: Website: www.lcgcevent.com/lcgcevent/v42/index.cvn?id=10003
Miscellaneous
15–16 August 2009
Fourier Transform Infrared Spectroscopy: A Hands-on Workshop
Washington, D.C.
Contact: Website: www.acs.org
15–16 August 2009
Introduction to Modern Mass Spectrometry
Washington, D.C.
Contact: Website: www.acs.org
15–16 August 2009
Introduction to Process Analytical Chemistry
Washington, D.C.
Contact: Website: www.acs.org
17–18 August 2009
Infrared Spectral Interpretation: A Systematic Approach
Washington, D.C.
Contact: Website: www.acs.org
19–20 August 2009
Tandem Mass Spectrometry of Biological Molecules
Washington, D.C.
Contact: Website: www.acs.org
21 August 2009
Chromatography for Non-Chemists: Security, Legal and Forensic Applications
Washington, D.C.
Contact: Website: www.acs.org
21 September 2009
Implement Key Validation Protocols for Chromatographic Methods
Philadelphia, PA.
Contact: Website: www.lcgcevent.com/lcgcevent/v42/index.cvn?id=10003
22 September 2009
A Generic Residual Solvents Method — Benefits, Rationale and Adaptations
Philadelphia, PA.
Contact: Website: www.lcgcevent.com/lcgcevent/v42/index.cvn?id=10003
22 September 2009
Discover the Importance of the Sample Preparation in Modern Pharmaceutical Analytical Practice
Philadelphia, PA.
Contact: Website: www.lcgcevent.com/lcgcevent/v42/index.cvn?id=10003
21–22 September 2009
Analysis and Interpretation of Mass Spectral Data
Chicago, IL.
Contact: Website: www.acs.org
12–13 October 2009
Capillary Electrophoresis of Biomolecules
Iselin, NJ.
Contact: Website: www.acs.org
21 October 2009
Writing Better NSF Research and Education Proposals
San Juan, Puerto Rico.
Contact: Website: www.sermacs2009.org/
21 October 2009
Chemical Reactivity Hazards, Laboratory Scale, Recognition & Control
San Juan, Puerto Rico.
Contact: Website: www.sermacs2009.org/
21 October 2009
The Laboratory Safety Workshop
San Juan, Puerto Rico.
Contact: Website: www.sermacs2009.org/
21 October 2009
How to be a More Effective Chemical Hygiene Officer
San Juan, Puerto Rico.
Contact: Website: www.sermacs2009.org/
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Profiling Volatile Organic Compounds in Whisky with GC×GC–MS
November 1st 2024Researchers from Austria, Greece, and Italy conducted a study to analyze volatile organic compounds (VOCs) present in Irish and Scotch whiskys using solid-phase microextraction (SPME) Arrow with comprehensive two-dimensional gas chromatography coupled to mass spectrometry (GC×GC–MS) to examine the organoleptic characteristics that influence the taste of spirits.
GC–TOF-MS Finds 250 Volatile Compounds in E-Cigarette Liquids
November 1st 2024A study has used gas chromatography coupled to a time-of-flight mass spectrometer to build an electron ionization mass spectra database of more than 250 chemicals classified as either volatile or semi-volatile compounds. An additional, confirmatory layer of liquid chromatography–mass spectrometry analysis was subsequently performed.
